GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Epsilon Healthcare EPN.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.02

—

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2025

Revenue

A$9.4m

FY2016FY2025

Net income

−A$1.3m

FY2016FY2025

Free cash flow

−A$3.3m

FY2016FY2025

Shareholders' equity

A$1.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueA$9.4mA$5.6mA$6.7mA$7.1mA$5.5mA$7.0mA$4.8mA$2.7mA$1.8m—
Research and development——A$53,748A$375,557A$171,097A$472,257A$140,297A$41,629——
Operating income−A$2.4m−A$4.5m−A$2.4m−A$8.0m−A$9.2m−A$10.8m−A$9.2m−A$8.5m−A$2.5m−A$207,666
Net income−A$1.3m−A$3.2m−A$1.1m−A$13.3m−A$9.2m−A$10.5m−A$11.7m−A$8.6m−A$2.6m−A$212,886
Diluted earnings per share-0.00-0.01-0.00-0.04-0.04-0.06-0.09-0.07-0.02-0.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsA$17.9mA$22.3mA$14.4mA$20.5mA$30.6mA$37.3mA$27.8mA$32.7mA$21.9mA$11.5m
Cash and short-term investmentsA$242,862A$1.6mA$343,013A$809,597A$2.3mA$7.0mA$3.6mA$6.3mA$11.0mA$3.6m
Total liabilitiesA$16.0mA$11.6mA$6.9mA$11.2mA$11.0mA$11.9mA$5.5mA$4.7mA$588,825A$116,994
DebtA$10.4mA$7.9mA$3.5mA$3.2mA$4.3mA$5.1mA$711,263A$408,120——
Shareholders' equityA$1.9mA$10.7mA$7.5mA$9.3mA$19.6mA$25.3mA$22.3mA$28.1mA$21.4mA$11.3m
Shares outstanding380m447m300m300m238m189m136m126m105m9m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−A$3.1m−A$3.4m−A$703,371−A$2.6m−A$5.4m−A$8.7m−A$7.9m−A$5.9m−A$1.9m−A$147,809
Capital spending−A$169,739−A$97,732−A$100,094−A$529,406−A$747,711−A$1.2m−A$714,679−A$3.0m−A$657,916—
Free cash flow−A$3.3m−A$3.5m−A$803,465−A$3.1m−A$6.1m−A$9.9m−A$8.6m−A$8.9m−A$2.5m−A$147,809
Dividends paid———−A$4.5m——————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueA$7.6mA$3.8mA$6.0mA$3.0mA$3.4m−A$3.0mA$2.7mA$1.4m
Operating income−A$1.2m−A$373,431−A$19,888A$142,064−A$2.4m−A$1.2m−A$1.6mA$378,571
Net income−A$725,972−A$362,986A$790,357A$395,178−A$2.1m−A$395,178−A$4.1m−A$903,718
Diluted earnings per share-0.00-0.000.000.00-0.01-0.00-0.01-0.00
Cash from operationsA$1.0m———−A$2.0m−A$1.0m−A$1.0m—
Capital spending————−A$2.0m———
Free cash flow————−A$4.0m———
Total assetsA$19.5mA$19.5mA$17.9mA$17.9mA$9.3mA$9.3mA$22.3mA$22.3m
Cash and short-term investmentsA$1.3mA$1.3mA$242,862A$242,862A$923,667A$923,667A$1.6mA$1.6m
DebtA$1.1mA$1.1mA$10.4mA$567,878A$9.1mA$3.8mA$7.9mA$7.9m
Shareholders' equityA$3.9mA$3.9mA$1.9mA$1.9m−A$3.6m−A$3.6mA$10.7mA$10.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.7%6.2%—
Operating income-33.2%-26.1%—
Net income-54.2%-34.4%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-9.8-3.3-6.6-0.6-1.8-4.2-4.4-6.8-28.0
Price to sales1.31.91.11.13.16.410.822.038.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.